Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | PDE1B | Q01064 | 8/20 | 0.38 |
| ▸ | PDE2A | O00408 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | NR1D1 | P20393 | 1/20 | 0.35 |
| ▸ | WNT3A | P56704 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31601772 | 0.90 | THRB (0.41) | THRBPDE1BPDE2AMAPTNAPEPLD | |
| SCHEMBL31601720 | 0.87 | THRB (0.36) | THRBPDE1BMAPTNAPEPLDRXFP1 | |
| SCHEMBL31601832 | 0.87 | PDE1B (0.36) | THRBPDE1BMAPTNAPEPLDRXFP1 | |
| SCHEMBL31601938 | 0.87 | THRB (0.36) | THRBPDE1BMAPTNAPEPLDRXFP1 | |
| SCHEMBL31601743 | 0.83 | PIK3CD (0.38) | THRBMAPTNAPEPLDRXFP1DGAT1 | |
| SCHEMBL31601853 | 0.81 | DGAT1 (0.40) | NAPEPLDDGAT1SOAT1 | |
| SCHEMBL31601880 | 0.81 | NR1D1 (0.34) | PDE1BMAPTRXFP1LMNANR1D1 | |
| SCHEMBL31601874 | 0.81 | DGAT1 (0.40) | NAPEPLDDGAT1SOAT1 | |
| SCHEMBL31601748 | 0.80 | NR1D1 (0.34) | THRBPDE1BLMNANR1D1 | |
| SCHEMBL31601736 | 0.80 | ALDH1A1 (0.34) | PDE1BMAPTRXFP1NR1D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110815-A1 | IMIDAZO [1,2-B] PYRIDAZINE-BASED NOVEL COMPOUND AS CDK INHIBITOR AND USE THEREOF | 아이리드비엠에스 주식회사 | 2025-05-30 | — | — | WO | disclosed |